In the newest EMPOWER podcast episode, Dr. Jacob Lang sits down with Dr. Josh Davidson (Alcon, Bausch + Lomb, Tarsus Pharmaceuticals) and Dr. Mark Dunbar (Azura Ophthalmics, Bausch + Lomb, Harrow, Sun Pharmaceutical) to discuss how modern dry eye management extends beyond a single treatment option. Together, they explore combination therapy, advances in pharmacology, meibomian gland dysfunction, and practical strategies for integrating new therapies into everyday clinical practice to help patients achieve more consistent relief.
advertisement
EMPOWER - Ocular Surface Disease: Latest Innovations In Dry Eye And Meibomian Gland Dysfunction
Share
Save
Restart
Resume
Transcript
EMPOWER - Ocular Surface Disease: Latest Innovations In Dry Eye And Meibomian Gland Dysfunction
closeShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Details
Presenters
Overview
In the newest EMPOWER podcast episode, Dr. Jacob Lang sits down with Dr. Josh Davidson (Alcon, Bausch + Lomb, Tarsus Pharmaceuticals) and Dr. Mark Dunbar (Azura Ophthalmics, Bausch + Lomb, Harrow, Sun Pharmaceutical) to discuss how modern dry eye management extends beyond a single treatment option. Together, they explore combination therapy, advances in pharmacology, meibomian gland dysfunction, and practical strategies for integrating new therapies into everyday clinical practice to help patients achieve more consistent relief.
Title
Program Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?